A Randomized Phase III Study of Weekly ABI-007 plus Gemc

Project: Research project

Project Details

Description

A Randomized Phase III Study of Weekly ABI-007 plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas
StatusFinished
Effective start/end date2/1/096/30/13

Funding

  • Abraxis BioScience, LLC

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.